SIGNIFICANCE OF STIMULATING GROWTH FACTOR ST2 AND NT-proBNP IN ASSESSMENT OF POSTINFARCTION REMODELING OF THE HEART

SIGNIFICANCE OF STIMULATING GROWTH FACTOR ST2 AND NT-proBNP IN ASSESSMENT OF POSTINFARCTION REMODELING OF THE HEART

Aim. To assess the levels of ST2 and NT-proBNP in serum of infarction patients (MI) in dynamics of hospital period and their relation with adaptive and desadaptive variants of myocardium remodeling.Material and methods. Totally, 87 patients (65 men and 22 women) with MI with ST elevation (STEMI), of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. A. Dyleva, O. V. Gruzdeva, O. E. Akbasheva, E. G. Uchasova, N. V. Fedorova, A. G. Chernobay, V. N. Karetnikova, S. N. Kosareva, V. V. Kashtalap, T. S. Fedorova, O. L. Barbarash
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2015-12-01
Series:	Российский кардиологический журнал
Subjects:	postinfarction remodeling stimulating growth factor st2
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/479
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Some pro- and anti-inflammatory cytokines, their genetic polymorphism and postinfarct cardiac remodeling
by: A. M. Nikolaeva, et al.
Published: (2020-11-01)

Twenty-year changes in the clinical and echocardiographic characteristics of patients with early postinfarction remodeling after primary ST-segment elevation myocardial infarction
by: A. M. Nikolaeva, et al.
Published: (2023-01-01)

CLINICAL TYPES OF POSTINFARCTION STATE
by: A. S. Galyavich
Published: (2016-03-01)

MECHANICAL AND PHARMACOLOGICAL SUPPORT OF BLOOD CIRCULATION IN SURGICAL TREATMENT OF LEFT VENTRICLE POSTINFARCTION ANEURISMS
by: V. V. Vitsukaev, et al.
Published: (2010-06-01)

GENDER DIFFERENCES OF CORONARY HEART DISEASE PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND CHRONIC MITRAL REGURGITATION BY THE DATA OF CORONARY ANGIOGRAPHY REGISTRY
by: E. I. Yaroslavskaya, et al.
Published: (2014-08-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)

The use of NT-proBNP in clinical practice
by: J.A. Ker
Published: (2004-12-01)

Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD
by: Benedikt Seither, et al.
Published: (2024-11-01)

CLINICAL AND ELECTROPHYSIOLOGICAL PREDICTORS OF RECURRENT POSTINFARCTION VENTRICULAR TACHICARDIAS AFTER CATHETER ABLATION
by: R. B. Tatarsky, et al.
Published: (2017-12-01)

Serum matrix metalloproteinase-2,9 activity, galectin-3 and systemic inflammation in patients with postinfarction heart failure with preserved ejection fraction.
by: O. Kuryata, et al.
Published: (2018-04-01)

Clinical case of the postinfarction ventricular septum defect successful closure with occluder at the 4th day of the disease
by: B.М. Todurov, et al.
Published: (2021-10-01)

Influence of L-carnitine on reactive oxygen species production by blood phagocytes in postinfarction cardiosclerosis patients
by: E. I. Astashkin, et al.
Published: (2016-10-01)

THE INFLUENCE OF LONG-TERM THERAPY WITH PERINDOPRIL ON THE HEART INOTROPIC FUNCTION IN PATIENTS WITH CHRONIC POSTINFARCTION ANEURISM
by: I. G. Fomina, et al.
Published: (2016-01-01)

TORASEMIDE IN PREVENTION OF MITRAL REGURGITATION AND CHRONIC HEART FAILURE WORSENING IN POSTINFARCTION PERIOD
by: A. A. Abdullaev, et al.
Published: (2018-06-01)

TAURIN INFLUENCE ON CLINICAL COURSE OF STAbLE ANGINA IN POSTINFARCTION CARDIOSCLEROSIS PATIENTS
by: I. S. Vasilieva, et al.
Published: (2018-05-01)

Structural and functional state of postinfarction myocardium and vascular endothelial growth factor: is there a connection?
by: A. M. Vorob'ev, et al.
Published: (2023-07-01)

Potential of NT-proBNP and sST2 rapid tests in patients with acute myocardial infarction
by: V. V. Ryabov, et al.
Published: (2023-07-01)

Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01)

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy
by: A. T. Teplyakov, et al.
Published: (2019-03-01)

SEGMENTAL ANALYSIS OF DIASTOLIC DYSFUNCTION OF THE LEFT VENTRICLE IN MYOCARDIAL POSTINFARCTION FOCAL CHANGES
by: D. A. Shvets, et al.
Published: (2016-08-01)

EFFECTIVENESS OF PHARMACOTHERAPY FOR NORMALIZATION OF THE BRAIN NATRIURETIC PEPTIDE, RENINE-ANGIOTENSINALDOSTERONE SYSTEM ACTIVATION AFTER SURGICAL REVASCULARIZATION OF MYOCARDIUM IN POSTINFARCTION CARDIOSCLEROSIS PATIENTS
by: S. A. Kovalev, et al.
Published: (2016-12-01)

Effect of NT-proBNP on Serum Calcium: A Longitudinal Analysis
by: Maria Rita Stancanelli, et al.
Published: (2025-04-01)

Navigating the challenges of NT-proBNP result disclosure in clinical research
by: Denise A. Kent, et al.
Published: (2025-01-01)

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
by: Gina Sado, et al.
Published: (2024-12-01)

HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD
by: A. A. Abdullaev, et al.
Published: (2016-01-01)

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016-01-01)

The Significance of the Cardiac Peptide NT-proBNP in the Assessment of Risk for Myocardial Revascularization in Patients with Decreased Left Ventricular Ejection Fraction
by: V. V. Moroz, et al.
Published: (2010-04-01)

Clinical value of BNP and NT-proBNP for evaluating the cardiac function of patients with chronic renal failure
by: TANG Li, et al.
Published: (2016-01-01)

Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19
by: V. I. Podzolkov, et al.
Published: (2023-01-01)

CLINICAL AND BIOCHEMICAL PREDICTORS OF DIABETES MELLITUS MANIFESTATION AFTER MYOCARDIAL INFARCTION
by: O. L. Barbarash, et al.
Published: (2014-03-01)

Joint Associations of Obesity and NT‐proBNP With the Incidence of Atrial Fibrillation in the ARIC Study
by: Zakaria Almuwaqqat, et al.
Published: (2019-10-01)

Prognostic significance of the biomarker NT-proBNP in the surgical treatment of aortic stenosis (pilot study)
by: I. A. Kozlov, et al.
Published: (2023-06-01)

Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
by: I. A. Kozlov, et al.
Published: (2023-02-01)

Prognostic value of NT-proBNP in the new era of heart failure treatment.
by: Dat Vu Nguyen, et al.
Published: (2024-01-01)

Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
by: H.M. Kim, et al.
Published: (2020-08-01)

The association of plasma NT-proBNP level and progression of diabetic kidney disease
by: Yuancheng Zhao, et al.
Published: (2023-12-01)

Dose-dependent effects of atorvastatin in the hospitalisation period of myocardial infarction
by: O. L. Barbarash, et al.
Published: (2013-06-01)

The Interplay between Adipose Tissue Properties and Levels of NT-proBNP in People with HIV
by: Mads-Holger Bang Jacobsen, et al.
Published: (2023-01-01)

The significance of NT-proBNP decline in the evaluation of heart failure during maintenance hemodialysis
by: LI Ping, et al.
Published: (2019-01-01)

Clinical Value of NT-proBNP and Lactate Parameters in Infants with Congenital Heart Defects
by: Narmin Akif Azizova
Published: (2024-11-01)